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 Background: Adequate hemostasis in cranial and spinal tumor surgery is of paramount importance in neurosurgical prac-
tice. Generalized ooze bleeding from the surgical walls cavity, coming from neoplastic vessels or nervous tis-
sue, may be problematic. Recent technical advances have dramatically reduced intraoperative complications 
related to blood loss. Several techniques are usually employed to control hemostasis in tumor surgery, includ-
ing preoperative embolization, intraoperative hypotension, electrical coagulation, and local application of fi-
brin sealants or hemostatic matrix, which influence coagulation.
 Material/Methods: Our aim in this study was to evaluate the efficacy and the safety of the Aquamantys® system (Medtronic 
Advanced Energy, Portsmouth, NH, USA), a novel bipolar coagulation device that incorporates a new bipolar 
coagulation technique. This device has been used in 10 consecutive patients affected by cerebral tumor along 
with the standard microsurgical technique and well-known intraoperative tools. The technique is associated 
with simultaneous delivery of bipolar radio frequency energy and conductive fluid through its electrode tip. 
The volume of saline passing by the electrode tip prevents charring and maintains a clean tip. This cools the 
tissue as it raises the temperature sufficiently to shrink the collagen of veins and arteries.
 Results: Effective hemostasis was achieved in all the cases. No complications or unwanted reactions associated with 
the device have been observed.
 Conclusions: Our findings suggest that the Aquamantys® system may be a highly effective adjuvant tool in minimizing blood 
loss in a patient with brain tumor, as well as reducing time of surgery.
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Background
Surgical treatment for intracranial tumor may be associated 
with blood loss. Several strategies are used to reduce blood 
loss, including preoperative embolization, intraoperative con-
trolled hypotension, electrical coagulation, or local application 
of fibrin sealants or hemostatic matrix, which influence coagu-
lation [1–3]. With usual contact methods involving electrocau-
tery, such as monopolar knife and bipolar coagulator, remov-
al of the probe from the adherent, desiccated eschar around 
the probe often detaches the eschar, causing greater bleeding 
than before the coagulation. In this scenario, the Aquamantys® 
system (Medtronic Advanced Energy, Portsmouth, NH, USA) in-
corporates a new bipolar coagulation technique [4] associated 
with simultaneous delivery of bipolar radio frequency energy 
and conductive fluid through its electrode tip. The volume of 
saline passing by the electrode tip prevents charring and main-
tains a clean tip. This cools the tissue as it raises the temper-
ature sufficiently to shrink the collagen of veins and arteries. 
Power and saline flow are adjustable for different types of tis-
sue to promote effective coagulation.
We report a series of brain tumor patients undergoing sur-
gery using the Aquamantys® system, along with its epidural 
vein sealer (EVS), which revealed some practical advantages. 
Usefulness and limitations are discussed.
Material	and	Methods
Informed patient consent has been obtained.
The Aquamantys® system (Medtronic Advanced Energy, 
Portsmouth, NH, USA) is based on a new bipolar coagulation 
technique, the so-called transcollation technology, a propri-
etary combination of radiofrequency energy and saline [4]. 
The technique is associated with simultaneous delivery of bi-
polar radio frequency energy and conductive fluid through its 
electrode tip.
Briefly, the system works by combining a bipolar electrosurgi-
cal generator with a rotary peristaltic pump to provide simul-
taneous delivery of radiofrequency energy and saline when 
used with Aquamantys® handheld disposable devices. The sa-
line cools the tissue as it is treated and evenly conducts the 
energy into the tissue to seal blood vessels. The thermal ef-
fect shrinks the collagen in the vessel walls of small arteries, 
and this results in the cessation of bleeding from these ves-
sels. The saline used as a conductive fluid cools the tissue sur-
face and prevents the surface temperature from getting too 
hot, thus avoiding charring.
The Aquamantys® device, when associated with the hand-
piece EVS, has a shaft diameter of 4 mm, thus offering good 
visibility and less crowdedness in the surgical field (Figure 1).
The Aquamantys® system has been used in 10 consecutive 
patients with brain tumors (5 meningiomas, 3 glioblastomas, 
and 2 pituitary adenomas). In cases with pituitary adenomas, 
the device was used for hemostasis of the bleeding from the 
nasal mucosa and on the tumor capsule.
The coagulation setting, adjustable from 20 to 200 watts, was 
20 watts and the saline flow (with settings for low, medium, 
and high), was set in “medium” position. External irrigation 
was also maintained as usual.
The device was used in the same way as standard electrocau-
tery except that the bipolar sealer could be used not only in 
a localized manner to stop bleeding, but also in a spreading 
manner to stop diffuse bleeding.
Results
Effective hemostasis was achieved in all cases. No complications 
or unwanted reactions associated with the device were observed.
Figure 1.  The Aquamantys® system consists of a 
proprietary radiofrequency generator 
that delivers transcollation technology 
to disposable Aquamantys bipolar 
sealers. The epidural vein sealer (EVS) 
handpiece has an out-of-body shaft 
length of 172.50 mm and a shaft 
diameter of 4 mm.
539
Indexed in: [Current Contents/Clinical Medicine] [SCI Expanded] [ISI Alerting System]  
[ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica]  
[Chemical Abstracts/CAS] [Index Copernicus]
Grasso G. et al.: 
Aquamantys system for brain tumor
© Med Sci Monit, 2014; 20: 538-543
This work is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivs 3.0 Unported License
PRODUCT INVESTIGATIONS
Hemostasis on tumor removal
On the removal of meningioma, at first, the tumor capsule was 
coagulated by the Aquamantys® device. This technique not only 
coagulated superficial blood vessels in the tumour capsule, but 
also produced shrinkage of the capsule due to the heating effect, 
facilitating the dissection of the tumor from the surrounding arach-
noid planes with minimal manipulation of surrounding structures.
The Aquamantys® probe can be used with both the naked eye 
and under the surgical microscope. A thin and a relative flexi-
ble probe (tip diameter of 3.4 mm, distal bayonet shaft length 
of 139.45 mm) particularly increased the usefulness of the 
system for hemostasis under the microscope. Thus, the total 
amount of bleeding was reduced and the reduction of the tumor 
size due to shrinking made it very easy to handle the tumors.
In glioma surgery, the device, with its relatively wide hand-
piece tip, allowed optimal tumor coagulation during dissection 
and stopped generalized ooze bleeding from the surrounding 
surgical wall cavity.
Hemostasis on skull base tumor removal
In brain tumors that have a large blood supply from feeding 
arteries penetrating the skull base, the Aquamantys® device 
A
B
C
Figure 2.  Preoperative axial (A), sagittal (B), and coronal (C) 
magnetic resonance imaging (MRI) scans with contrast 
showing a mass lesion in the left cerebellopontine 
angle entering the left sigmoid sinus.
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was extremely useful for the hemostasis of these bone-pene-
trating feeding arteries.
Hemostasis of the nasal mucosa
The Aquamantys® device was also useful for troublesome bleed-
ing from the nasal mucosa with the endonasal approach for a 
pituitary adenoma. By using its long distal bayonet, it was pos-
sible to stop the bleeding from the sidewall of the nasal mu-
cosa. Furthermore, the Aquamantys® device was very useful 
in coagulating the tumor capsule, leading to lesion shrinking.
Illustrative case
A 52-year-old woman was admitted with mild occasional head-
ache and disequilibrium. Neurological examination on admis-
sion showed mild left hearing impairment and mild gait distur-
bance with ataxia. No other neurological findings (e.g., facial 
dysesthesia or facial palsy) were observed.
No familial history of neurofibromatosis was evident.
The patient underwent brain computed tomography (CT), 
which showed a lesion in the left cerebellopontine angle. 
Magnetic resonance imaging demonstrated a mass lesion in 
the left cerebellopontine angle. The mass was approximate-
ly 6 cm in diameter, appearing hypointense on T1-weighted 
imaging, and heterogeneously intense on T2-weighted imag-
ing. The lesion had peritumoral edema apparent in the sur-
rounding cerebellum on fluid-attenuated inversion recovery 
imaging. The mass had a solid lobular shape with heteroge-
neous enhancement after contrast administration. The tumor 
margins were clear and no contact with the internal audito-
ry meatus was evident. Slight dural tail sign was evident on 
the left sigmoid sinus, which was infiltrated but not occlud-
ed by the lesion (Figure 2).
Left suboccipital retrosigmoid craniotomy exposed the tumor 
originating from the tentorium, and present mainly in the in-
fratentorial epiarachnoid space, with a small attachment to 
the edge of the petrosal bone. The lesion was well demarcat-
ed from the surrounding cerebellum, but attachment to the 
petrosal vein was identified. The lesion was carefully dissected 
out by the surrounding cerebellum. The Aquamantys® device 
was used both for tumor capsule coagulation and meningio-
ma shrinking (Figure 3). Bipolar coagulation and ultrasound 
suction were used to achieve tumor resection. A small piece 
of tumor was left inside the sigmoid sinus. Histological exam-
ination of the tumor demonstrated typical findings of menin-
gothelial meningioma. Postoperatively, the patient showed no 
neurological deficit and recovered well. Two years later, brain 
MRI follow-up did not show development of the residual tu-
mor inside the left sigmoid sinus (Figure 4).
Discussion
The development of bipolar coagulation began with the broad 
thermal-dispersion electrodes and has evolved to include high-
ly accurate devices that deliver thermal energy via nonstick 
methods. Over time, the operative range of coagulation in-
struments has dramatically increased and improved. However, 
most of the contact methods of electrocautery have 2 short-
comings [5]. First, despite suction and irrigation, they work 
in the pooled blood. Coagulation in a bloody field only leads 
to boiling and then carbonization of the blood. Second, the 
coagulation of the pooled blood and not the bleeding vessel 
leads to the formation of a coating eschar around the probe. 
Removal of the probe from the adherent, desiccated eschar 
often detaches the eschar, causing greater bleeding than be-
fore the coagulation. In these contexts, a new electrosurgery 
modality, the Aquamantys® system, which has been used suc-
cessfully in orthopedic [4,6,7], general and cardiac surgery [8], 
is gaining interest as an innovative method.
A
B
Figure 3.  Intraoperative photographs showing the tumor in the 
left cerebellopontine angle. The Aquamantys® system 
is used to coagulate the tumor capsule (A). This allows 
a rapid devascularization, as shown by the progressive 
capsule discoloration (B).
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The Aquamantys® system and bipolar sealers feature innovative 
Transcollation® technology, a combination of radiofrequency 
(RF) energy and saline that provides hemostatic sealing of soft 
tissue and bone during surgery [4]. It consists of a generator 
and disposable, single-use handpieces. The generator delivers 
transcollation technology, simultaneous RF power and saline 
delivery, to the disposable bipolar sealers. Power settings can 
vary from 20 to 200 watts and 3 different flow rates can be se-
lected. Various handpieces are available that are adept for use 
in specific surgical procedures. The 6.0 Bipolar Sealer is mainly 
used in orthopedic surgery, where the system has been dem-
onstrated to be useful in reducing blood loss during hip and 
knee replacement procedures and trauma surgery [4,9]. The 
EVS, with its out-of-body shaft length of 172 mm and shaft di-
ameter of 4 mm, is recently used during spine surgery such as 
decompression procedures (e.g., discectomy and laminectomy) 
and all procedures requiring access to the epidural space [9].
In our surgical procedures, we used the EVS handpiece. The 
coagulation setting was 20 watts and saline flow was set at 
medium.
Compared with other high-frequency contact coagulation meth-
ods, the depth of necrosis, due to thermal injury, is extreme-
ly superficial and the continuous saline irrigation reduces the 
temperature in and around the treated area, which is crucial-
ly advantageous for neurosurgical operations. The use of stan-
dard electrocautery results in a high tissue surface temperature 
A
B
C
Figure 4.  Postoperative axial (A), sagittal (B), and coronal 
(C) magnetic resonance imaging (MRI) scans with 
contrast showing no recurrence of the lesion at 2-year 
follow-up.
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and therefore leads to charring of the tissue and scar forma-
tion. Preventing this charring and searing of the tissue by us-
ing the Aquamantys® device should avoid the possible postop-
erative breakage or detachment of scar and clots produced by 
conventional electrocautery, which can lead to postoperative 
blood loss. Since the Aquamantys® system uses a round hand-
piece tip, the tissue surface that can be treated is larger than 
that usually coagulated by the classical bipolar forceps. This 
feature allows better control of capillary ooze, a well-known 
problem at the end of intracerebral tumor removal, and a wide 
coagulation area of the tumor and its capsule. In meningio-
ma surgery, capsule coagulation leads to tumor devascular-
ization; by increasing the power of the transcollation technol-
ogy, tumor shrinking can be obtained. Furthermore, in skull 
base meningioma, when Simpson grade I cannot be achieved 
[10], the Aquamantys® tip device allows an efficacious coag-
ulation of dural attachment.
Aquamantys® device can be applied in a brushwork fashion 
over large areas and it is particularly well-suited for treating 
diffuse bleeding and broad tumors, even when it is difficult to 
determine the bleeding point. Furthermore, since the device 
does not cause carbonization or vaporization and hence does 
not generate smoke, the surgeon’s operative view is not dis-
turbed. The relatively low initial cost and operating expenses 
are additional advantages of this technique.
The disadvantages of Aquamantys® should also be consid-
ered. In some instances, when the bleeding comes from a 
well-recognized broken vein or artery, the bipolar forceps are 
more adequate and precise in controlling the bleeding than is 
the Aquamantys® system. Furthermore, the limited flexibility 
of the handpiece is a drawback, especially in case of a deep, 
narrow, and irregular operating channel. In such a case, how-
ever, the bipolar coagulation needs a wide enlargement of the 
working channel to provide complete control of the bleeding.
Conclusions
The Aquamantys® system is a novel coagulation technique 
with an innovative Transcollation® technology, a combina-
tion of radiofrequency (RF) energy and saline that provides 
hemostatic sealing of soft tissue and bone during surgery [4].
This technology can be considered as an adjuvant strategy for 
achieving hemostasis in brain tumor surgery. The Aquamantys® 
device is complementary to rather than competitive with bi-
polar coagulation and a conventional monopolar knife. The 
use of this device is certainly no substitute for a good micro-
surgical hemostasis technique. With the development of tai-
lored and more flexible probes, the device might become a 
valuable surgical device.
Disclosure
The authors have no personal financial or institutional inter-
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